window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : August 20, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

pancreatic ductal adenocarcinoma

  • Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    Elicio misses Phase 2 endpoint but advances Phase 3 plan for pancreatic cancer immunotherapy

    Elicio Therapeutics has reported that its Phase 2 Amplify-7P trial [...]

    June 15, 2026
  • Advanced Therapies,Clinical & Regulatory,Therapeutic Areas

    CuraCell reports pancreatic cancer findings from personalised TIL therapy programme

    CuraCell TX has reported new findings supporting its personalised tumour-infiltrating [...]

    June 8, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    NETRIS Pharma Nature publishes pancreatic cancer Phase 1b data showing NP137 survival and surgery gains

    Nature publishes Phase 1b data showing NETRIS Pharma’s NP137 improves [...]

    May 5, 2026

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Prescient integrates Uptake and Dolon to create 550-strong pharma consultancy
    Categories: Biotech & Pharma Business
  • Tris Pharma partners with Calm Health and ADHD Central to support patients
    Categories: Digital & Data, Pharmaceuticals and therapeutics, Therapeutic Areas
  • US FDA inspects Aurisco site for generic oligonucleotide manufacturing
    Categories: Drug Discovery & Development, Manufacturing & Supply Chain, Pharmaceuticals and therapeutics, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top